Search
2023 Volume 3
Article Contents
REVIEW   Open Access    

Research progress on the antidiabetic activities of tea and its bioactive components

More Information
  • Diabetes mellitus (DM) is a pressing global public health issue with a high incidence of morbidity and mortality due to its complications. Although there are many medicines available for the treatment of DM, long-term use causes various adverse effects, such as diarrhea, vomiting, and nausea. Tea, owing to its richness of diverse bioactive components including tea polyphenols, tea polysaccharides, and alkaloids, has displayed promising antidiabetic properties. Screening antidiabetic bioactive compounds derived from teas is receiving increasing attention. Epidemiological and clinical investigations have demonstrated an inverse relationship between tea consumption and the incidence of DM. Both in vitro and in vivo experiments have substantiated the hypoglycemic effects of tea and its bioactive components through several possible mechanisms, including improvement of insulin resistance, inhibition of carbohydrates digestion and absorption (inhibit α-amylase and α-glucosidase activity), regulations of gut microbiota, inflammatory cytokines, and gene and protein expressions in the insulin signaling pathway, as well as amelioration of DM complications. This comprehensive review provides an up-to-date overview of the hypoglycemic properties associated with tea and its bioactive components. It also delves into their potential mechanisms, offering a theoretical foundation for further research into tea's antidiabetic properties and for the development of innovative antidiabetic functional products.
  • 加载中
  • [1]

    Zheng Y, Ley SH, Hu FB. 2018. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nature Reviews Endocrinology 14:88−98

    doi: 10.1038/nrendo.2017.151

    CrossRef   Google Scholar

    [2]

    Magliano DJ, Boyko EJ, committee IDFDAtes. 2021. IDF Diabetes Atlas 2021.10th Edition. Brussels: International Diabetes Federation. pp. 33

    [3]

    Fu QY, Li QS, Lin XM, Qiao RY, Yang R, et al. 2017. Antidiabetic effects of tea. Molecules 22:849

    doi: 10.3390/molecules22050849

    CrossRef   Google Scholar

    [4]

    Venkatakrishnan K, Chiu HF, Wang CK. 2019. Popular functional foods and herbs for the management of type-2-diabetes mellitus: A comprehensive review with special reference to clinical trials and its proposed mechanism. Journal of Functional Foods 57:425−38

    doi: 10.1016/j.jff.2019.04.039

    CrossRef   Google Scholar

    [5]

    Zhang L, Ho CT, Zhou J, Santos JS, Armstrong L, et al. 2019. Chemistry and biological activities of processed Camellia sinensis teas: A comprehensive review. Comprehensive Reviews in Food Science and Food Safety 18:1474−95

    doi: 10.1111/1541-4337.12479

    CrossRef   Google Scholar

    [6]

    Sanlier N, Atik İ, Atik A. 2018. A minireview of effects of white tea consumption on diseases. Trends in Food Science & Technology 82:82−88

    doi: 10.1016/j.jpgs.2018.10.004

    CrossRef   Google Scholar

    [7]

    Nie J, Yu C, Guo Y, Pei P, Chen L, et al. 2021. Tea consumption and long-term risk of type 2 diabetes and diabetic complications: a cohort study of 0.5 million Chinese adults. The American Journal of Clinical Nutrition 114:194−202

    doi: 10.1093/ajcn/nqab006

    CrossRef   Google Scholar

    [8]

    Hosoda K, Wang MF, Liao ML, Chuang CK, Iha M, et al. 2003. Antihyperglycemic effect of oolong tea in type 2 diabetes. Diabetes Care 26(6):1714−18

    doi: 10.2337/diacare.26.6.1714

    CrossRef   Google Scholar

    [9]

    Cao S, Zhao C, Gan R, Xu X, Wei X, et al. 2019. Effects and mechanisms of tea and its bioactive compounds for the prevention and treatment of cardiovascular diseases: An updated review. Antioxidants 8:166

    doi: 10.3390/antiox8060166

    CrossRef   Google Scholar

    [10]

    Jin Y, Arroo R. 2023. The protective effects of flavonoids and carotenoids against diabetic complications-A review of in vivo evidence. Frontiers in Nutrition 10:1020950

    doi: 10.3389/fnut.2023.1020950

    CrossRef   Google Scholar

    [11]

    Wan C, Ouyang J, Li M, Rengasamy KRR, Liu Z. 2022. Effects of green tea polyphenol extract and epigallocatechin-3-O-gallate on diabetes mellitus and diabetic complications: Recent advances. Critical Reviews in Food Science and Nutrition 00:1−29

    doi: 10.1080/10408398.2022.2157372

    CrossRef   Google Scholar

    [12]

    Duan WX, Yang XH, Zhang HF, Feng J, Zhang MY. 2022. Chemical structure, hypoglycemic activity, and mechanism of action of selenium polysaccharides. Biological Trace Element Research 200:4404−18

    doi: 10.1007/s12011-021-03035-z

    CrossRef   Google Scholar

    [13]

    Yaribeygi H, Jamialahmadi T, Moallem SA, Sahebkar A. 2021. Boosting GLP-1 by natural products. In Natural Products and Human Diseases. Advances in Experimental Medicine and Biology, eds. Sahebkar A, Sathyapalan T. vol 1328. Cham: Springer. pp. 513−22. https://doi.org/10.1007/978-3-030-73234-9_36

    [14]

    Proença C, Ribeiro D, Freitas M, Fernandes E. 2022. Flavonoids as potential agents in the management of type 2 diabetes through the modulation of α-amylase and α-glucosidase activity: A review. Critical Reviews in Food Science and Nutrition 62:3137−207

    doi: 10.1080/10408398.2020.1862755

    CrossRef   Google Scholar

    [15]

    Tao W, Zhou Z, Zhao B, Wei T. 2016. Simultaneous determination of eight catechins and four theaflavins in green, black and oolong tea using new HPLC-MS-MS method. Journal of Pharmaceutical and Biomedical Analysis 131:140−45

    doi: 10.1016/j.jpba.2016.08.020

    CrossRef   Google Scholar

    [16]

    Huang F, Li Y, Yang P, Liu ZH, Huang JA, et al. 2022. Relationship between theanine, catechins and related genes reveals accumulation mechanism during spring and summer in tea plant (Camellia sinensis L.). Scientia Horticulturae 302:111142

    doi: 10.1016/j.scienta.2022.111142

    CrossRef   Google Scholar

    [17]

    Tang GY, Meng X, Gan RY, Zhao CN, Liu Q, et al. 2019. Health functions and related molecular mechanisms of tea components: An update review. International Journal of Molecular Sciences 20:6196

    doi: 10.3390/ijms20246196

    CrossRef   Google Scholar

    [18]

    Koch W, Kukula-Koch W, Komsta Ł. 2018. Black tea samples origin discrimination using analytical investigations of secondary metabolites, antiradical scavenging activity and chemometric approach. Molecules 23:513

    doi: 10.3390/molecules23030513

    CrossRef   Google Scholar

    [19]

    Zhang H, Qi R, Mine Y. 2019. The impact of oolong and black tea polyphenols on human health. Food Bioscience 29:55−61

    doi: 10.1016/j.fbio.2019.03.009

    CrossRef   Google Scholar

    [20]

    Dai W, Xie D, Lu M, Li P, Lv H, et al. 2017. Characterization of white tea metabolome: Comparison against green and black tea by a nontargeted metabolomics approach. Food Research International 96:40−45

    doi: 10.1016/j.foodres.2017.03.028

    CrossRef   Google Scholar

    [21]

    Fang ZT, Song CJ, Xu HR, Ye JH. 2019. Dynamic changes in flavonol glycosides during production of green, yellow, white, oolong and black teas from Camellia sinensis L. (cv. Fudingdabaicha). International Journal of Food Science & Technology 54:490−98

    doi: 10.1111/ijfs.13961

    CrossRef   Google Scholar

    [22]

    Du LL, Fu QY, Xiang LP, Zheng XQ, Lu JL, et al. 2016. Tea polysaccharides and their bioactivities. Molecules 21:1449

    doi: 10.3390/molecules21111449

    CrossRef   Google Scholar

    [23]

    Jahanban-Esfahlan A, Panahi-Azar V. 2016. Interaction of glutathione with bovine serum albumin: Spectroscopy and molecular docking. Food Chemistry 202:426−31

    doi: 10.1016/j.foodchem.2016.02.026

    CrossRef   Google Scholar

    [24]

    Ji X, Guo J, Cao T, Zhang T, Liu Y, et al. 2023. Review on mechanisms and structure-activity relationship of hypoglycemic effects of polysaccharides from natural resources. Food Science and Human Wellness 12:1969−80

    doi: 10.1016/j.fshw.2023.03.017

    CrossRef   Google Scholar

    [25]

    Zhang S, Jin J, Chen J, Ercisli S, Chen L. 2022. Purine alkaloids in tea plants: component, biosynthetic mechanism and genetic variation. Beverage Plant Research 2:13

    doi: 10.48130/bpr-2022-0013

    CrossRef   Google Scholar

    [26]

    Yang C, Hu Z, Lu M, Li P, Tan J, et al. 2018. Application of metabolomics profiling in the analysis of metabolites and taste quality in different subtypes of white tea. Food Research International 106:909−19

    doi: 10.1016/j.foodres.2018.01.069

    CrossRef   Google Scholar

    [27]

    Ning JM, Ding D, Song YS, Zhang ZZ, Luo X, et al. 2016. Chemical constituents analysis of white tea of different qualities and different storage times. European Food Research and Technology 242:2093−104

    doi: 10.1007/s00217-016-2706-0

    CrossRef   Google Scholar

    [28]

    Consortium I, van Woudenbergh GJ, Kuijsten A, Drogan D, van der AD, et al. 2012. Tea consumption and incidence of type 2 diabetes in Europe: the EPIC-InterAct case-cohort study. PLoS ONE 7:e36910

    doi: 10.1371/journal.pone.0036910

    CrossRef   Google Scholar

    [29]

    Hamer M, Witte DR, Mosdøl A, Marmot MG, Brunner EJ. 2008. Prospective study of coffee and tea consumption in relation to risk of type 2 diabetes mellitus among men and women: the Whitehall II study. British Journal of Nutrition 100:1046−53

    doi: 10.1017/S0007114508944135

    CrossRef   Google Scholar

    [30]

    van Dieren S, Uiterwaal CSPM, van der Schouw YT, van der A DL, Boer JMA, et al. 2009. Coffee and tea consumption and risk of type 2 diabetes. Diabetologia 52:2561−69

    doi: 10.1007/s00125-009-1516-3

    CrossRef   Google Scholar

    [31]

    Iso H, Date C, Wakai K, Fukui M, Tamakoshi A. 2006. The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. Annals of Internal Medicine 144:554−62

    doi: 10.7326/0003-4819-144-8-200604180-00005

    CrossRef   Google Scholar

    [32]

    Li Y, Wang C, Huai Q, Guo F, Liu L, et al. 2016. Effects of tea or tea extract on metabolic profiles in patients with type 2 diabetes mellitus: a meta-analysis of ten randomized controlled trials. Diabetes/Metabolism Research and Reviews 32:2−10

    doi: 10.1002/dmrr.2641

    CrossRef   Google Scholar

    [33]

    Xu R, Bai Y, Yang K, Chen G. 2020. Effects of green tea consumption on glycemic control: A systematic review and meta-analysis of randomized controlled trials. Nutrition & Metabolism 17:56

    doi: 10.1186/s12986-020-00469-5

    CrossRef   Google Scholar

    [34]

    Huxley R, Lee CMY, Barzi F, Timmermeister L, Czernichow S, et al. 2009. Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: A systematic review with meta-analysis. Archives of Internal Medicine 169:2053−63

    doi: 10.1001/archinternmed.2009.439

    CrossRef   Google Scholar

    [35]

    Jing Y, Han G, Hu Y, Bi Y, Li L, et al. 2009. Tea consumption and risk of type 2 diabetes: A meta-analysis of cohort studies. Journal of General Internal Medicine 24:557−62

    doi: 10.1007/s11606-009-0929-5

    CrossRef   Google Scholar

    [36]

    Hayashino Y, Fukuhara S, Okamura T, Tanaka T, Ueshima H, et al. 2011. High oolong tea consumption predicts future risk of diabetes among Japanese male workers: a prospective cohort study. Diabetic Medicine 28:805−10

    doi: 10.1111/j.1464-5491.2011.03239.x

    CrossRef   Google Scholar

    [37]

    Curtis PJ, Sampson M, Potter J, Dhatariya K, Kroon PA, et al. 2012. Chronic ingestion of flavan-3-ols and isoflavones improves insulin sensitivity and lipoprotein status and attenuates estimated 10-year CVD risk in medicated postmenopausal women with type 2 diabetes: A 1-year, double-blind, randomized, controlled trial. Diabetes Care 35:226−32

    doi: 10.2337/dc11-1443

    CrossRef   Google Scholar

    [38]

    Ma Q, Chen D, Sun HP, Yan N, Xu Y, et al. 2015. Regular Chinese green tea consumption is protective for diabetic retinopathy: A clinic-based case-control study. Journal of Diabetes Research 2015:231570

    doi: 10.1155/2015/231570

    CrossRef   Google Scholar

    [39]

    Brown AL, Lane J, Coverly J, Stocks J, Jackson S, et al. 2009. Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: Randomized controlled trial. British Journal of Nutrition 101:886−94

    doi: 10.1017/S0007114508047727

    CrossRef   Google Scholar

    [40]

    Fukino Y, Ikeda A, Maruyama K, Aoki N, Okubo T, et al. 2008. Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities. European Journal of Clinical Nutrition 62:953−60

    doi: 10.1038/sj.ejcn.1602806

    CrossRef   Google Scholar

    [41]

    Ortsäter H, Grankvist N, Wolfram S, Kuehn N, Sjöholm A. 2012. Diet supplementation with green tea extract epigallocatechin gallate prevents progression to glucose intolerance in db/db mice. Nutrition & Metabolism 9:11

    doi: 10.1186/1743-7075-9-11

    CrossRef   Google Scholar

    [42]

    Tsuneki H, Murata S, Anzawa Y, Soeda Y, Tokai E, et al. 2008. Age-related insulin resistance in hypothalamus and peripheral tissues of orexin knockout mice. Diabetologia 51:657−67

    doi: 10.1007/s00125-008-0929-8

    CrossRef   Google Scholar

    [43]

    Li M, Luo X, Ho CT, Li D, Guo H, et al. 2022. A new strategy for grading of Lu'an guapian green tea by combination of differentiated metabolites and hypoglycaemia effect. Food Research International 159:111639

    doi: 10.1016/j.foodres.2022.111639

    CrossRef   Google Scholar

    [44]

    Zhou J, Zhang L, Meng Q, Wang Y, Long P, et al. 2018. Roasting improves the hypoglycemic effects of a large-leaf yellow tea infusion by enhancing the levels of epimerized catechins that inhibit α-glucosidase. Food & Function 9:5162−68

    doi: 10.1039/c8fo01429a

    CrossRef   Google Scholar

    [45]

    Zhao G, Teng J, Dong R, Ban Q, Yang L, et al. 2023. Alleviating effects and mechanisms of action of large-leaf yellow tea drinking on diabetes and diabetic nephropathy in mice. Food Science and Human Wellness 12:1660−73

    doi: 10.1016/j.fshw.2023.02.023

    CrossRef   Google Scholar

    [46]

    Neyestani TR, Shariatzade N, Kalayi A, Gharavi A, Khalaji N, et al. 2010. Regular daily intake of black tea improves oxidative stress biomarkers and decreases serum C-reactive protein levels in type 2 diabetic patients. Annals of Nutrition and Metabolism 57:40−49

    doi: 10.1159/000312666

    CrossRef   Google Scholar

    [47]

    Ramalingam S, Ramasamy SM, Vasu G, Gopalarishnan R. 2020. Antihyperglycemic potential of back tea extract attenuates tricarboxylic acid cycle enzymes by modulating carbohydrate metabolic enzymes in streptozotocin-induced diabetic rats. Indian Journal of Clinical Biochemistry 35:322−30

    doi: 10.1007/s12291-019-00831-2

    CrossRef   Google Scholar

    [48]

    Alves MG, Martins AD, Teixeira NF, Rato L, Oliveira PF, et al. 2015. White tea consumption improves cardiac glycolytic and oxidative profile of prediabetic rats. Journal of Functional Foods 14:102−10

    doi: 10.1016/j.jff.2015.01.019

    CrossRef   Google Scholar

    [49]

    Ding Q, Zheng W, Zhang B, Chen X, Zhang J, et al. 2019. Comparison of hypoglycemic effects of ripened pu-erh tea and raw pu-erh tea in streptozotocin-induced diabetic rats. RSC Advances 9:2967−77

    doi: 10.1039/C8RA09259A

    CrossRef   Google Scholar

    [50]

    Qi B, Ren D, Li T, Niu P, Zhang X, et al. 2022. Fu Brick Tea manages HFD/STZ-induced type 2 diabetes by regulating the gut microbiota and activating the IRS1/PI3K/Akt signaling pathway. Journal of Agricultural and Food Chemistry 70:8274−87

    doi: 10.1021/acs.jafc.2c02400

    CrossRef   Google Scholar

    [51]

    Zhu J, Wu M, Zhou H, Cheng L, Wei X, et al. 2021. Liubao brick tea activates the PI3K-Akt signaling pathway to lower blood glucose, metabolic disorders and insulin resistance via altering the intestinal flora. Food Research International 148:110594

    doi: 10.1016/j.foodres.2021.110594

    CrossRef   Google Scholar

    [52]

    Norris JM, Rich SS. 2012. Genetics of glucose homeostasis: implications for insulin resistance and metabolic syndrome. Arteriosclerosis, Thrombosis, and Vascular Biology 32:2091−96

    doi: 10.1161/ATVBAHA.112.255463

    CrossRef   Google Scholar

    [53]

    Yu J, Song P, Perry R, Penfold C, Cooper AR. 2017. The effectiveness of green tea or green tea extract on insulin resistance and glycemic control in type 2 diabetes mellitus: A meta-analysis. Diabetes & Metabolism Journal 41:251−62

    doi: 10.4093/dmj.2017.41.4.251

    CrossRef   Google Scholar

    [54]

    Lin CL, Lin JK. 2008. Epigallocatechin gallate (EGCG) attenuates high glucose-induced insulin signaling blockade in human hepG2 hepatoma cells. Molecular Nutrition & Food Research 52:930−39

    doi: 10.1002/mnfr.200700437

    CrossRef   Google Scholar

    [55]

    Qin B, Polansky MM, Harry D, Anderson RA. 2010. Green tea polyphenols improve cardiac muscle mRNA and protein levels of signal pathways related to insulin and lipid metabolism and inflammation in insulin-resistant rats. Molecular Nutrition & Food Research 54:S14−S23

    doi: 10.1002/mnfr.200900306

    CrossRef   Google Scholar

    [56]

    Luo C, Yang H, Tang C, Yao G, Kong L, et al. 2015. Kaempferol alleviates insulin resistance via hepatic IKK/NF-κB signal in type 2 diabetic rats. International Immunopharmacology 28:744−50

    doi: 10.1016/j.intimp.2015.07.018

    CrossRef   Google Scholar

    [57]

    Li B, Fu L, Kojima R, Yamamoto A, Ueno T, et al. 2021. Theaflavins prevent the onset of diabetes through ameliorating glucose tolerance mediated by promoted incretin secretion in spontaneous diabetic Torii rats. Journal of Functional Foods 86:104702

    doi: 10.1016/j.jff.2021.104702

    CrossRef   Google Scholar

    [58]

    Zhou H, Wu Y, Kim E, Pan H, He P, et al. 2021. Simultaneous tests of theaflavin-3,3'-digallate as an anti-diabetic drug in human hepatoma G2 cells and Zebrafish (Danio rerio). Nutrients 13:4379

    doi: 10.3390/nu13124379

    CrossRef   Google Scholar

    [59]

    Xu J, Wang M, Zhao J, Wang YH, Tang Q, et al. 2018. Yellow tea (Camellia sinensis L.), a promising Chinese tea:Processing, chemical constituents and health benefits. Food Research International 107:567−77

    doi: 10.1016/j.foodres.2018.01.063

    CrossRef   Google Scholar

    [60]

    Xiang G, Sun H, Chen Y, Guo H, Liu Y, et al. 2023. Antioxidant and hypoglycemic activity of tea polysaccharides with different degrees of fermentation. International Journal of Biological Macromolecules 228:224−33

    doi: 10.1016/j.ijbiomac.2022.12.114

    CrossRef   Google Scholar

    [61]

    Lin HC, Lee CT, Yen YY, Chu CL, Hsieh YP, et al. 2019. Systematic review and meta-analysis of anti-hyperglycaemic effects of Pu-erh tea. International Journal of Food Science & Technology 54:516−25

    doi: 10.1111/ijfs.13966

    CrossRef   Google Scholar

    [62]

    Lee BH, Yan L, Phillips RJ, Reuhs BL, Jones K, et al. 2013. Enzyme-synthesized highly branched maltodextrins have slow glucose generation at the mucosal α-glucosidase level and are slowly digestible in vivo. PLoS ONE 8:e59745

    doi: 10.1371/journal.pone.0059745

    CrossRef   Google Scholar

    [63]

    Zheng Y, Tian J, Yang W, Chen S, Liu D, et al. 2020. Inhibition mechanism of ferulic acid against α-amylase and α-glucosidase. Food Chemistry 317:126346

    doi: 10.1016/j.foodchem.2020.126346

    CrossRef   Google Scholar

    [64]

    Gao J, Zhou M, Chen D, Xu J, Wang Z, et al. 2023. High-throughput screening and investigation of the inhibitory mechanism of α-glucosidase inhibitors in teas using an affinity selection-mass spectrometry method. Food Chemistry 422:136179

    doi: 10.1016/j.foodchem.2023.136179

    CrossRef   Google Scholar

    [65]

    Sun L, Warren FJ, Netzel G, Gidley MJ. 2016. 3 or 3′-Galloyl substitution plays an important role in association of catechins and theaflavins with porcine pancreatic α-amylase: The kinetics of inhibition of α-amylase by tea polyphenols. Journal of Functional Foods 26:144−56

    doi: 10.1016/j.jff.2016.07.012

    CrossRef   Google Scholar

    [66]

    Liu S, Ai Z, Meng Y, Chen Y, Ni D. 2021. Comparative studies on the physicochemical profile and potential hypoglycemic activity of different tea extracts: Effect on sucrase-isomaltase activity and glucose transport in Caco-2 cells. Food Research International 148:110604

    doi: 10.1016/j.foodres.2021.110604

    CrossRef   Google Scholar

    [67]

    Fei Q, Gao Y, Zhang X, Sun Y, Hu B, et al. 2014. Effects of Oolong tea polyphenols, EGCG, and EGCG3″Me on pancreatic α-amylase activity in vitro. Journal of Agricultural and Food Chemistry 62:9507−14

    doi: 10.1021/jf5032907

    CrossRef   Google Scholar

    [68]

    Şöhretoğlu D, Sari S, Barut B, Özel A. 2018. Discovery of potent α-glucosidase inhibitor flavonols: Insights into mechanism of action through inhibition kinetics and docking simulations. Bioorganic Chemistry 79:257−64

    doi: 10.1016/j.bioorg.2018.05.010

    CrossRef   Google Scholar

    [69]

    Deng YT, Lin-Shiau SY, Shyur LF, Lin JK. 2015. Pu-erh tea polysaccharides decrease blood sugar by inhibition of α-glucosidase activity in vitro and in mice. Food & Function 6:1539−46

    doi: 10.1039/c4fo01025f

    CrossRef   Google Scholar

    [70]

    Xu P, Wu J, Zhang Y, Chen H, Wang Y. 2014. Physicochemical characterization of puerh tea polysaccharides and their antioxidant and α-glycosidase inhibition. Journal of Functional Foods 6:545−54

    doi: 10.1016/j.jff.2013.11.021

    CrossRef   Google Scholar

    [71]

    Zhu J, Zhou H, Zhang J, Li F, Wei K, et al. 2021. Valorization of polysaccharides obtained from dark tea: Preparation, physicochemical, antioxidant, and hypoglycemic properties. Foods 10:2276

    doi: 10.3390/foods10102276

    CrossRef   Google Scholar

    [72]

    Guo H, Fu MX, Wu DT, Zhao YX, Li H, et al. 2021. Structural characteristics of crude polysaccharides from 12 selected Chinese teas, and their antioxidant and anti-diabetic activities. Antioxidants 10:1562

    doi: 10.3390/antiox10101562

    CrossRef   Google Scholar

    [73]

    Nie Q, Chen H, Hu J, Fan S, Nie S. 2019. Dietary compounds and traditional Chinese medicine ameliorate type 2 diabetes by modulating gut microbiota. Critical Reviews in Food Science and Nutrition 59:848−63

    doi: 10.1080/10408398.2018.1536646

    CrossRef   Google Scholar

    [74]

    Gurung M, Li Z, You H, Rodrigues R, Jump DB, et al. 2020. Role of gut microbiota in type 2 diabetes pathophysiology. EBioMedicine 51:102590

    doi: 10.1016/j.ebiom.2019.11.051

    CrossRef   Google Scholar

    [75]

    Han S, Luo Y, Hu Z, Qin D, Luo F. 2022. Targeting gut microbiota in type 2 diabetes mellitus: Potential roles of dietary flavonoids. Food Bioscience 45:101500

    doi: 10.1016/j.fbio.2021.101500

    CrossRef   Google Scholar

    [76]

    Chen G, Xie M, Wan P, Chen D, Dai Z, et al. 2018. Fuzhuan Brick Tea polysaccharides attenuate metabolic syndrome in high-fat diet induced mice in association with modulation in the gut microbiota. Journal of Agricultural and Food Chemistry 66:2783−95

    doi: 10.1021/acs.jafc.8b00296

    CrossRef   Google Scholar

    [77]

    Huang H, Chen J, Hu X, Chen Y, Xie J, et al. 2022. Elucidation of the interaction effect between dietary fiber and bound polyphenol components on the anti-hyperglycemic activity of tea residue dietary fiber. Food & Function 13:2710−28

    doi: 10.1039/d1fo03682c

    CrossRef   Google Scholar

    [78]

    Park JM, Shin Y, Kim SH, Jin M, Choi JJ. 2020. Dietary epigallocatechin-3-gallate alters the gut microbiota of obese diabetic db/db mice: Lactobacillus is a putative target. Journal of Medicinal Food 23:1033−42

    doi: 10.1089/jmf.2020.4700

    CrossRef   Google Scholar

    [79]

    Li H, Fang Q, Nie Q, Hu J, Yang C, et al. 2020. Hypoglycemic and hypolipidemic mechanism of tea polysaccharides on type 2 diabetic rats via gut microbiota and metabolism alteration. Journal of Agricultural and Food Chemistry 68:10015−28

    doi: 10.1021/acs.jafc.0c01968

    CrossRef   Google Scholar

    [80]

    Ding Q, Zhang B, Zheng W, Chen X, Zhang J, et al. 2019. Liupao tea extract alleviates diabetes mellitus and modulates gut microbiota in rats induced by streptozotocin and high-fat, high-sugar diet. Biomedicine & Pharmacotherapy 118:109262

    doi: 10.1016/j.biopha.2019.109262

    CrossRef   Google Scholar

    [81]

    Lontchi-Yimagou E, Sobngwi E, Matsha TE, Kengne AP. 2013. Diabetes mellitus and inflammation. Current Diabetes Reports 13:435−44

    doi: 10.1007/s11892-013-0375-y

    CrossRef   Google Scholar

    [82]

    Eitah HE, Maklad YA, Abdelkader NF, Gamal el Din AA, Badawi MA, et al. 2019. Modulating impacts of quercetin/sitagliptin combination on streptozotocin-induced diabetes mellitus in rats. Toxicology and Applied Pharmacology 365:30−40

    doi: 10.1016/j.taap.2018.12.011

    CrossRef   Google Scholar

    [83]

    Yamauchi R, Kobayashi M, Matsuda Y, Ojika M, Shigeoka S, et al. 2010. Coffee and caffeine ameliorate hyperglycemia, fatty liver, and inflammatory adipocytokine expression in spontaneously diabetic KK-A y mice. Journal of Agricultural and Food Chemistry 58:5597−603

    doi: 10.1021/jf904062c

    CrossRef   Google Scholar

    [84]

    Lin YL, Tsai SH, Lin-Shiau SY, Ho CT, Lin JK. 1999. Theaflavin-3, 3'-digallate from black tea blocks the nitric oxide synthase by down-regulating the activation of NF-κB in macrophages. European Journal of Pharmacology 367:379−88

    doi: 10.1016/S0014-2999(98)00953-4

    CrossRef   Google Scholar

    [85]

    Shang A, Li J, Zhou DD, Gan RY, Li HB. 2021. Molecular mechanisms underlying health benefits of tea compounds. Free Radical Biology and Medicine 172:181−200

    doi: 10.1016/j.freeradbiomed.2021.06.006

    CrossRef   Google Scholar

    [86]

    Waltner-Law ME, Wang XL, Law BK, Hall RK, Nawano M, et al. 2002. Epigallocatechin gallate, a constituent of green tea, represses hepatic glucose production. Journal of Biological Chemistry 277:34933−40

    doi: 10.1074/jbc.M204672200

    CrossRef   Google Scholar

    [87]

    Wolfram S, Raederstorff D, Preller M, Wang Y, Teixeira SR, et al. 2006. Epigallocatechin gallate supplementation alleviates diabetes in rodents. The Journal of Nutrition 136:2512−18

    doi: 10.1093/jn/136.10.2512

    CrossRef   Google Scholar

    [88]

    Qiu J, Maekawa K, Kitamura Y, Miyata Y, Tanaka K, et al. 2014. Stimulation of glucose uptake by theasinensins through the AMP-activated protein kinase pathway in rat skeletal muscle cells. Biochemical Pharmacology 87:344−51

    doi: 10.1016/j.bcp.2013.10.029

    CrossRef   Google Scholar

    [89]

    Wang H, Shi S, Bao B, Li X, Wang S. 2015. Structure characterization of an arabinogalactan from green tea and its anti-diabetic effect. Carbohydrate Polymers 124:98−108

    doi: 10.1016/j.carbpol.2015.01.070

    CrossRef   Google Scholar

    [90]

    Li S, Chen H, Wang J, Wang X, Hu B, et al. 2015. Involvement of the PI3K/Akt signal pathway in the hypoglycemic effects of tea polysaccharides on diabetic mice. International Journal of Biological Macromolecules 81:967−74

    doi: 10.1016/j.ijbiomac.2015.09.037

    CrossRef   Google Scholar

    [91]

    Xu Y, Zhang M, Wu T, Dai S, Xu J, et al. 2015. The anti-obesity effect of green tea polysaccharides, polyphenols and caffeine in rats fed with a high-fat diet. Food & Function 6:297−304

    doi: 10.1039/c4fo00970c

    CrossRef   Google Scholar

    [92]

    Murase T, Misawa K, Haramizu S, Hase T. 2009. Catechin-induced activation of the LKB1/AMP-activated protein kinase pathway. Biochemical Pharmacology 78:78−84

    doi: 10.1016/j.bcp.2009.03.021

    CrossRef   Google Scholar

    [93]

    Anter E, Chen K, Shapira OM, Karas RH, Keaney Jr JF. 2005. p38 mitogen-activated protein kinase activates eNOS in endothelial cells by an estrogen receptor alpha-dependent pathway in response to black tea polyphenols. Circulation Research 96:1072−78

    doi: 10.1161/01.RES.0000168807.63013.56

    CrossRef   Google Scholar

    [94]

    Kim J, Kim CS, Moon MK, Kim JS. 2015. Epicatechin breaks preformed glycated serum albumin and reverses the retinal accumulation of advanced glycation end products. European Journal of Pharmacology 748:108−14

    doi: 10.1016/j.ejphar.2014.12.010

    CrossRef   Google Scholar

    [95]

    Borges CM, Papadimitriou A, Duarte DA, Lopes de Faria JM, Lopes de Faria JB. 2016. The use of green tea polyphenols for treating residual albuminuria in diabetic nephropathy: A double-blind randomised clinical trial. Scientific Reports 6:28282

    doi: 10.1038/srep28282

    CrossRef   Google Scholar

    [96]

    Xia X, Wang X, Wang H, Lin Z, Shao K, et al. 2021. Ameliorative effect of white tea from 50-year-old tree of Camellia sinensis L.(Theaceae) on kidney damage in diabetic mice via SIRT1/AMPK pathway. Journal of Ethnopharmacology 272:113919

    doi: 10.1016/j.jep.2021.113919

    CrossRef   Google Scholar

    [97]

    Xu P, Chen H, Wang Y, Hochstetter D, Zhou T, et al. 2012. Oral administration of puerh tea polysaccharides lowers blood glucose levels and enhances antioxidant status in alloxan-induced diabetic mice. Journal of Food Science 77:H246−H252

    doi: 10.1111/j.1750-3841.2012.02950.x

    CrossRef   Google Scholar

    [98]

    Yi W, Xie X, Du M, Bu Y, Wu N, et al. 2017. Green tea polyphenols ameliorate the early renal damage induced by a high-fat diet via ketogenesis/SIRT3 pathway. Oxidative Medicine and Cellular Longevity 2017:9032792

    doi: 10.1155/2017/9032792

    CrossRef   Google Scholar

    [99]

    Fiorino P, Evangelista FS, Santos F, Magri FMM, Delorenzi JCMOB, et al. 2012. The effects of green tea consumption on cardiometabolic alterations induced by experimental diabetes. Experimental Diabetes Research 2012:309231

    doi: 10.1155/2012/309231

    CrossRef   Google Scholar

    [100]

    Li YM, Zhang XG, Zhou HL, Chen SH, Zhang Y, et al. 2004. Effects of tea polyphenols on hepatic fibrosis in rats with alcoholic liver disease. Hepatobiliary & Pancreatic Diseases International 3:577−79

    Google Scholar

  • Cite this article

    Gao J, Chen D, Lin Z, Peng J, Yu S, et al. 2023. Research progress on the antidiabetic activities of tea and its bioactive components. Beverage Plant Research 3:32 doi: 10.48130/BPR-2023-0032
    Gao J, Chen D, Lin Z, Peng J, Yu S, et al. 2023. Research progress on the antidiabetic activities of tea and its bioactive components. Beverage Plant Research 3:32 doi: 10.48130/BPR-2023-0032

Figures(2)  /  Tables(2)

Article Metrics

Article views(4532) PDF downloads(581)

REVIEW   Open Access    

Research progress on the antidiabetic activities of tea and its bioactive components

Beverage Plant Research  3 Article number: 32  (2023)  |  Cite this article

Abstract: Diabetes mellitus (DM) is a pressing global public health issue with a high incidence of morbidity and mortality due to its complications. Although there are many medicines available for the treatment of DM, long-term use causes various adverse effects, such as diarrhea, vomiting, and nausea. Tea, owing to its richness of diverse bioactive components including tea polyphenols, tea polysaccharides, and alkaloids, has displayed promising antidiabetic properties. Screening antidiabetic bioactive compounds derived from teas is receiving increasing attention. Epidemiological and clinical investigations have demonstrated an inverse relationship between tea consumption and the incidence of DM. Both in vitro and in vivo experiments have substantiated the hypoglycemic effects of tea and its bioactive components through several possible mechanisms, including improvement of insulin resistance, inhibition of carbohydrates digestion and absorption (inhibit α-amylase and α-glucosidase activity), regulations of gut microbiota, inflammatory cytokines, and gene and protein expressions in the insulin signaling pathway, as well as amelioration of DM complications. This comprehensive review provides an up-to-date overview of the hypoglycemic properties associated with tea and its bioactive components. It also delves into their potential mechanisms, offering a theoretical foundation for further research into tea's antidiabetic properties and for the development of innovative antidiabetic functional products.

    • Diabetes mellitus (DM) is a metabolic disorder resulting from compromised insulin action or insufficient insulin secretion[1]. It is characterized by persistent hyperglycemia and glycosuria, accompanied by multisystem and multiorgan complications, such as diabetic nephropathy and diabetic retinopathy[1]. Over the past few years, there has been a rapid increase in the prevalence of DM. According to the latest data released by the International Diabetes Federation, about 537 million adults aged 20−79 suffered DM in 2021, and this number will reach nearly 643 million by 2030 and approximately 783 million by 2045[2]. Currently, there are two main types of DM, type I diabetes (T1DM) and type II diabetes (T2DM), with T2DM constituting roughly 90%−95% of all cases. T1DM is distinguished by a complete absence of insulin due to the autoimmune destruction of pancreatic β-cells, whereas T2DM is characterized by insulin deficiency and reduced insulin sensitivity[3]. As a severe threat to both global economies and human health, DM has reached a crisis level and is one of the foremost public health challenges of the 21st century. Despite the availability of numerous medications for clinical DM treatment, long-term use still causes adverse effects, such as nausea, diarrhea, and weight gain[4]. Thus, there is a great need to develop alternative natural hypoglycemic agents.

      Tea (Camellia sinensis) is one of the world's most popular beverages, which originates from China and has been used as a beverage and medicine for more than 5,000 years[5]. According to the differences in the fermentation degree and manufacturing processes, it can be categorized into dark, black, yellow, white, oolong, and green tea[6]. The potential hypoglycemic effects of tea and its active ingredients have been extensively studied in recent years. Epidemiological and clinical investigations have demonstrated an inverse relationship between regular tea consumption and the incidence of DM[7,8]. Furthermore, a large number of in vitro and in vivo researches have illuminated the capacity of tea and its bioactive compounds (e.g., tea polyphenols, tea polysaccharides, and alkaloids) to mitigate the risk of DM and its associated complications to some extent through different mechanisms of action[3,9]. Therefore, the development of antidiabetic medicines from tea and its bioactive components is receiving increasing attention. This review summarizes the recent research progress on tea bioactive compounds and their hypoglycemic effects and discusses the potential hypoglycemic mechanisms of tea. It will be helpful for further research on the antidiabetic activities of tea and the development of new antidiabetic functional products.

    • The primary objective in managing DM is to attain optimal glycemic control and to stave off or slow down the emergence and advancement of DM complications[10]. A fundamental component of contemporary DM management encompasses the utilization of clinical medications aimed at regulating blood glucose levels. These medications, owing to the multifaceted nature of DM's pathophysiology, operate via a variety of mechanisms to modulate glucose levels[4,1113], which can be divided into five main categories (as shown in Table 1): (1) In an oral or injection form, insulin can be administered to hormone-deficient T1DM patients and T2DM patients with poor glycemic management. (2) Another approach to manage DM involves the usage of insulin sensitizers, exemplified by thiazolidinediones and biguanides. Thiazolidinediones, like pioglitazone and rosiglitazone, alongside biguanides such as metformin and buformin, generally enhance insulin receptor sensitivity in peripheral tissues like muscle, adipose tissue, and liver, thereby ameliorating insulin resistance. (3) Insulin secretion enhancers such as sulfonylureas are another treatment option. Oral sulfonylureas (e.g., glimepiride, gliquidone, gliclazide, and glipizide) stimulate insulin secretion from pancreatic β-cells. Nevertheless, it's worth noting that sulfonylureas can provoke insulin secretion independently of glucose levels, potentially leading to episodes of hypoglycemia. (4) Therapeutic medications based on incretin hormones, such as dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon-like peptide 1 (GLP-1) receptor agonists, offer additional treatment options. (5) Other drugs, including α-glucosidase inhibitors and sodium-glucose cotransporter-2 (SGLT2) inhibitors, are other treatment options. Notably, commonly used α-glucosidase inhibitors like miglitol, voglibose, and acarbose may induce side effects like gastric flatulence and diarrhea with long-term use[14]. SGLT2 inhibitors increase renal glucose excretion by decreasing renal tubular reabsorption of glucose[14]. Antidiabetic medications may be administered as single agents or combined in dual or triple therapy regimens to effectively manage hyperglycemia. However, despite their efficacy in treating DM, these hypoglycemic medications are highly susceptible to a variety of adverse effects with long-term use, including weight gain, hypoglycemia, nephron- and hepatotoxicity, allergies, and abdominal discomfort (diarrhea, vomiting, and nausea)[4,1113]. Moreover, they are also expensive. Therefore, there is a high demand for alternative natural hypoglycemic drugs for the management of DM.

      Table 1.  Summary of the categories of hypoglycemic medicines, common clinical drugs, hypoglycemic mechanisms, and adverse effects.

      Categories of hypoglycemic medicinesCommon clinical drugsHypoglycemic mechanismsAdverse effects
      InsulinInsulinEnhance glucose uptake and utilization by systemic tissues and cells while inhibiting glycogenolysis and glycogen isogenesis.Hypersensitivity, lipodystrophy, and lipohypertrophy
      ThiazolidinedionesRosiglitazone; PioglitazoneIncrease insulin sensitivity in liver, muscle, and adipose tissue.Abnormal liver function and weight gain
      BiguanidesPioglitazone; Buformin; MetforminInhibit hepatic glucose output, improve the insulin sensitivity of peripheral tissues, and increase glucose uptake and utilization.Loss of appetite, nausea, abdominal discomfort, and diarrhea
      SulfonylureasGlimepiride; Gliquidone; Gliclazide; GlipizideReduce blood glucose levels by stimulating β-cells insulin secretion.Hypoglycemic reaction, loss of appetite, nausea and vomiting, diarrhea, and increased risk of cardiovascular disease
      Dipeptidyl peptidase-4
      (DPP-4) inhibitors
      Linagliptin; Saxagliptin; VigliptinReduce glucagon and hypoglycemia.Nasopharyngitis, headache, and upper respiratory tract infection
      Glucagon-like peptide 1
      (GLP-1) receptor agonist
      Lixisenatide; Albiglutide; Dulaglutide; SemaglutideReduce blood glucose levels by increasing insulin secretion and inhibiting postprandial glucagon secretion.Nausea, vomiting, diarrhea, injection-site inflammation, and pancreatitis
      α-Glucosidase inhibitorsAcrobose; Miglitol; VogliboseHinder the decomposition and absorption
      of dietary carbohydrates by inhibiting pancreatic α-amylase and intestinal α-glucosidase.
      Gastric flatulence and diarrhea
      Sodium-glucose-cotransporter type-2 (SGLT-2) inhibitorsCanagliflozin; Ertugliflozin; Dapagliflozin; EmpagliflozinInhibit glucose reabsorption in the kidney and eliminate glucose from the urine.Urinary tract infection
    • Tea contains various bioactive components, some of which remain unchanged in the tea leaves, while others undergo transformations during processing. The potential hypoglycemic compounds in tea predominantly comprise tea polyphenols, tea polysaccharides, and alkaloids[5], and the contents of these main compounds of teas are highly dependent on tea categories[15].

    • Tea polyphenols are a group of polyhydroxy phenolic compounds, which constitute a major group of biologically active components, comprising around 25% of the dry weight of tea and are mainly composed of flavanols (catechins and dimeric catechins) and flavonoid glycosides[5,14].

    • Catechins, a member of the flavanols family, account for over 70% of tea polyphenols and are the major chemical contributors to tea flavor and bioactivities[5,14]. As shown in Fig. 1, catechins mainly include nonester-type catechins, such as epigallocatechin (EGC), catechin (C), epicatechin (EC), and gallocatechin (GC), and ester-type catechins, such as epigallocatechin-3-O-gallate (EGCG), catechin-3-O-gallate (CG), epicatechin-3-O-gallate (ECG), and gallocatechin-3-O-gallate (GCG). Among these compounds, ester catechins are present at higher levels than nonester-type catechins[16]. Due to the processing methods used, the catechin contents in different tea categories can vary greatly. For example, white, green, and yellow teas contain higher catechin levels compared to oolong, black, and dark teas[17]. Furthermore, the contents of catechins can also be influenced by variety and geographic factors; for example, the contents of EGC can be 10 times different in the major black tea producing countries[18].

      Figure 1. 

      Chemical structures of the primary polyphenols in tea.

    • Theaflavins (TFs) and theasinensins (TSs) are two important types of dimeric catechins, which primarily form through enzyme-catalyzed reactions during the fermentation process and are commonly found in fermented teas like oolong, black, and white teas[19]. TFs, mainly include theaflavin-3,3′-digallate (TF-DG), theaflavin (TF), theaflavin-3′-gallate (TF-3′-G), and theaflavin-3-gallate (TF-3-G), constituting approximately 3%−5% (w/w) of the solid extract in black tea and are a compound class of benzotropolone derivatives (Fig. 1)[5]. In our previous study, we found that theasinesins (theasinesin A and theasinesin B) exhibited higher levels in white tea (slightly fermented) and reached their peak in black tea (fully fermented), while they were lowest in green tea (unfermented), indicating that the formation of theasinesins is related to the fermentation degree[20].

    • Flavonoid glycosides are the main polyphenols in tea and have potential antidiabetic bioactivity, which comprises about 3%−4% of the dry weight of tea[21]. The flavonoid glycosides in tea differ in their aglycones and conjugated sugars. In terms of aglycones, they can be classified into quercetin, myricetin, kaempferol, and apigenin glycosides; in terms of the number of glycoside moieties, they can be classified into mono-, di-, and tri-glycosides; in terms of conjugated sugars, they can be categorized into glucoside, galactoside, rutinoside, and arabinoside[21].

    • Tea polysaccharides consist of a diverse array of water-soluble polysaccharides, pectin, and proteins extracted from various parts of the tea plant, including leaves, flowers, and seed peels[22]. These heteropolysaccharides have garnered significant attention due to their numerous health benefits, such as their potential to regulate lipid metabolism, act as antioxidants, and offer antidiabetic effects[23]. The content and composition of tea polysaccharides are influenced by factors like tea tree variety, leaf maturity, and processing technique. It has been shown that fresh leaves with higher maturity have a higher content of tea polysaccharides[24]. In addition, the hypoglycemic activity of polysaccharides have been linked to their molecular weights and structures, with higher molecular weight generally exhibiting weaker hypoglycemic effects[24].

    • Tea plants contain primarily purine alkaloids, notably caffeine, theobromine, and theophylline, which not only contribute to tea's flavor but also possess significant physiological and biological functions[25,26]. Caffeine, the most abundant purine alkaloid in tea, typically constitutes 1.5%−5% of the dry weight of tea leaves, though it varies with the variety and the growing environment of tea plants[26]. Additionally, there is a considerable disparity in caffeine content between mature and young tea leaves, with new shoots being reported to accumulate significantly higher levels compared to mature leaves[27].

    • Extensive research has been conducted on the impact of tea on DM and its associated complications. In recent years, epidemiological investigations and clinical trials have demonstrated an inverse relationship between regular tea consumption and the occurrence of DM. Additionally, both in vitro and in vivo experimental studies have underscored the beneficial effects of tea in the prevention and management of DM.

    • Given the global prevalence of tea consumption, numerous epidemiological studies have been conducted to explore the hypoglycemic properties of tea. For example, a European cohort study found that individuals who consumed a minimum of four cups of tea daily had a 20% lower risk of developing T2DM compared to nondrinkers (hazard ratio (HR) = 0.84, 95% CI (0.71, 1.00))[28]. Another study tracked 5,823 British subjects over an 11.7-year period and revealed a significant negative correlation (HR: 0.66; 95% CI: 0.61−1.22; p value < 0.05) between tea consumption and DM risk after adjustment for age, sex, ethnicity, and social status[29]. Similarly, a prospective cohort study involving 500,000 Chinese adults reported HRs of 0.90 (95% CIs: 0.83, 0.97) for all-cause mortality and 0.88 (95% CIs: 0.78, 1.00) for the risk of microvascular complications among daily tea drinkers compared to non-drinkers[7]. A 10-year follow-up study of 40,011 Dutch people found that tea consumption has an inverse association with T2DM, with an HR of 0.63 (95% CI: 0.47−0.86), and consumption of three or more cups of tea per day were 42% less likely to develop T2DM than nondrinkers[30]. In a retrospective cohort study, individuals in Japan who consumed more than six cups of green tea daily had a multivariable odds ratio (OR) for DM of 0.67 (95% CI, 0.47−0.94), whereas there was no significant association with the incidence of DM for those consuming black or oolong teas[31]. The effects of tea on DM were also investigated in several meta-analyses. For instance, a meta-analysis involving 608 patients with T2DM in China showed that tea consumption led to a reduction in fasting blood insulin levels by 1.30 U/L (95% CI: 0.36−2.24) over an intervention period lasting more than eight weeks[32]. Another meta-analysis comprising 27 studies with 2,194 participants found that green tea significantly lowered fasting glucose (1.44 mg/dL, 95% CI: −2.26 to −0.62 mg/dL; p value < 0.001)[33]. In addition, another meta-analysis showed that people who drank more than four cups of tea per day reduced the risk of T2DM by 20% (relative risk (RR), 0.82 (95% CI, 0.73−0.94)) than those who had never consumed tea[34]. Nonetheless, some epidemiological investigations have yielded contradictory results. A review of nine cohort studies involving a total of 324,141 participants and 11,400 incident DM cases, followed for 5 to 18 years, found no association between tea consumption and the incidence of T2DM (RR, 0.96; 95% CI: 0.92−1.01)[35]. In addition, the multivariable-adjusted HR for the development of DM was 1.64 (95% CI: 1.11−2.40) for those who consumed more than two cups of oolong tea every day than nondrinkers[36]. These inconsistent findings may be attributed to the differences in the sensitivities to tea in different populations, individual differences in subjects, the kinds of tea consumed, and the drinking manner of teas.

      In conclusion, a variety of epidemiologic evidence supports the positive role of tea consumption in mitigating DM and its complications, although there are instances of conflicting findings. These discrepancies may be attributed to factors such as the tea dosage, categories, and frequencies of tea consumption, as well as the tested individual differences. In addition, there is still a paucity of studies on the association between tea consumption and DM complications, which needs to be further investigated.

    • Numerous clinical trials have delved into the potential of tea as a therapeutic agent for DM. For instance, a randomized, double-blind, placebo-controlled, and parallel trial revealed that a one-year intervention using flavan-3-ols (major compounds in tea) improved biomarkers of cardiovascular disease (CVD) risk by reducing insulin resistance and improving insulin sensitivity[37]. Another clinical trial observed a preventive effect of long-term green tea consumption on diabetic retinopathy, with regular green tea drinkers experiencing a roughly 50% reduction in the risk of diabetic retinopathy compared to nondrinkers (OR = 0.49, 95% CI (0.26–0.90))[38]. Multiple randomized controlled trials have indicated that the daily intake of polyphenols and green tea extract has the capacity to improve tolerance to oral glucose among individuals possessing a clean bill of health while simultaneously decreasing fasting plasma glucose and glycosylated hemoglobin levels[39,40]. Hence, it is plausible that green tea may serve a valuable purpose in augmenting glycemic control and reducing insulin resistance among individuals with T2DM. In addition, a clinical trial involving Taiwanese patients with diabetes who were taking hypoglycemic drugs revealed that oolong tea served as an effective adjunctive oral hypoglycemic agent for treating T2DM[8].

      In short, clinical trials have shown that tea helps prevent and control DM and its complications primarily through the improvement of insulin resistance and reduction of postprandial glucose levels.

    • The effects of tea on DM and its complications have been extensively studied in teas of different categories through in vitro and in vivo experimental studies in recent years.

      Several experimental animal studies have provided evidence of the potential of green tea extract to enhance insulin sensitivity and reduce blood glucose levels in diabetic mice[41,42]. According to the leaf morphology and sensory evaluation, Lu'an guapian green tea (LGGT) can be categorized into five grades (ranging from low to high): summer grade (SuG), third grade (TG), second grade (SG), first grade (FG), second premium (SP), and first premium (FP)[43]. In addition, it was found that higher grades were associated with improved glucose tolerance and insulin sensitivity in mice fed with a high-fat diet[43]. Zhou et al. found that roasted yellow tea could reduce fasting blood glucose levels and improve insulin sensitivity by strongly inhibiting α-glucosidase activity[44]. Additionally, the administration of large-leaf yellow tea was observed to improve impaired insulin resistance and glucose tolerance in mice with diet-induced diabetes[45]. Black tea, known for its anti-inflammatory and antioxidant effects, proves beneficial for T2DM by inhibiting various radicals, leading to reduced blood glucose levels[46]. In addition, black tea extract significantly lowered glycosylated hemoglobin and fasting glucose levels in diabetic rats while increasing plasma insulin levels in a dose-dependent manner[47]. White tea showed antidiabetic activity through the reduction of insulin resistance, hyperlipidemia, and oxidative stress[6]. Furthermore, prediabetic rats that consumed white tea for two months showed higher insulin sensitivity and lower glucose intolerance than control rats[48]. In the realm of Pu-erh tea, extracts from ripened Pu-erh tea were found to improve gut microbiota composition, particularly enhancing the abundance and diversity of beneficial bacterial species like Alloprevotella, Prevotellaceae NK3B31 group, and Lactobacillus in rats with streptozotocin-induced diabetes[49]. Notably, these effects were more pronounced in rats treated with ripened Pu-erh tea than in those treated with raw Pu-erh tea[49]. Similarly, Fu brick tea extract was demonstrated to have positive effects on gut dysbiosis in T2DM, by reducing the Firmicutes/Bacteroidota (F/B) ratio and promoting the proliferation of beneficial genera like Parabacteroides, Bifidobacterium, and Roseburia[50]. It has been reported that Liubao brick tea has an excellent hypoglycemic effect and significantly ameliorates metabolic disorders caused by hyperglycemia, mainly by enhancing intestinal flora diversity, including increasing beneficial bacteria, decreasing harmful bacteria, and improving metabolic disorders and insulin resistance[51].

    • The mechanisms by which the bioactive components of tea (tea polyphenols, tea polysaccharides, and alkaloids) help prevent and treat DM and its complications mainly include improving insulin resistance, inhibiting carbohydrate digestion and absorption (inhibiting α-amylase and α-glucosidase activity), regulating gut microbiota, inflammatory cytokines, and gene and protein expressions in the insulin signaling pathway, as well as ameliorating DM complications (as shown in Fig. 2 & Table 2).

      Figure 2. 

      The mechanisms of tea bioactive components (tea polyphenols, polysaccharides, and alkaloids) help prevent and treat DM and its complications (image source from Freepik.com).

      Table 2.  The effects and mechanisms of tea and its bioactive components on DM based on in vitro and in vivo studies

      Tea/bioactive componentsAnimal modelsDoses (day)Duration (weeks)Effects and mechanismsRef.
      Yellow tea extractC57BL/6J mice60 or 120 mg/kg10Improves impaired glucose tolerance, pyruvate tolerance, and insulin resistance.[45]
      Black tea extractWistar rats25, 50, or 100 mg/kg30 dDecreases the level of glucose, glycated hemoglobin and increases the levels of insulin.[47]
      White tea extractWistar rats/8Improves glucose tolerance and insulin sensitivity.[48]
      Pu-erh tea extractWistar rats120, 160, 600, or
      800 mg/kg
      6Increases the abundance of the beneficial bacteria.[49]
      Fu brick tea extractC57BL/6J mice100, 200, or
      400 mg/kg
      8Ameliorates the T2DM-induced gut dysbiosis by decreasing the Firmicutes/Bacteroidota ratio at the phylum level.[50]
      Liubao tea extractC57BL/6J mice834 or 1,667 mg/kg10Increases the diversity of intestinal flora.[51]
      Tea polyphenolsWistar rats200 mg/kg6Improves insulin sensitivity and decreases the inflammatory factors.[55]
      KaempferolSprague–Dawley rats50 or 150 mg/kg10Enhances insulin sensitivity.[56]
      TheaflavinsSpontaneously diabetic torii rats25 mg/kg20Improves impaired glucose tolerance.[57]
      Tea polysaccharidesICR mice150, 200, or 300 mg/kg4Improves insulin resistance.[60]
      EGCG; Epiafzelechin-3-gallate; ECG///Exhibits inhibitory effects against α-glucosidase.[64]
      Oolong tea polyphenols; EGCG; EGCG3″Me///Exhibits inhibitory effects against α-amylase.[67]
      Quercetin-3-O-(6″-O-galloyl)-β-galactopyranoside; Quercetin-3-O-(3″-O-galloyl)-β-glucopyranoside///Exhibits inhibitory effects against α-glucosidase.[68]
      Tea polysaccharidesICR mice1 or 5 mg/kg/Exhibits inhibitory effects against α-glucosidase.[69]
      Tea polysaccharidesICR mice50 mg/kg/Exhibits inhibitory effects against α-glucosidase.[70]
      Tea polysaccharides///Exhibits inhibitory effects against α-amylase and α-glucosidase.[71]
      Tea polysaccharides///Exhibits inhibitory effects against α-glucosidase.[72]
      Tea polysaccharidesC57BL/6 mice200, 400, or
      800 mg/kg
      8Increases the phylogenetic diversity of HFD-induced microbiota.[76]
      EGCGDb/db mice10, 50, or 100 mg/kg8Increases the abundance of beneficial bacteria.[78]
      Tea polysaccharidesWistar rats100, 200, or
      400 mg/kg
      /Modulates gut microbiota diversity and increases the abundance of beneficial genera.[79]
      QuercetinWistar rats50 mg/kg3Exhibits anti-inflammatory activity.[82]
      CaffeineKK-Ay mice250 mg/L5Reduces inflammatory cytokine expression (TNFα, IL-6, and MCP-1).[83]
      EGCGDb/db mice2.5, 5.0, or 10.0 g/kg7Decreases the PEPCK mRNA expression in the adipose and liver tissues.[87]
      Tea polyphenolsWistar rats200 mg/kg6Upregulates the insulin signaling protein levels.[55]
      Tea polysaccharidesKunming mice200, 400, or
      800 mg/kg
      4Upregulates the expressions of the critical proteins in the PI3K/Akt signal pathway including GLUT4, p-Akt, and PI3K.[90]
      Tea polyphenols; Tea polysaccharides; CaffeineSprague–Dawley rats400 or 800 mg/kg6Reduces rat serum leptin levels, inhibits the absorption of fatty acids, and reduces the expression levels of the IL-6 and
      TNF-α genes.
      [91]
      ECSprague–Dawley rats50 or 100 mg/kg2Improves advanced glycation end products-induced retinal vascular injury.[94]
    • Insulin resistance, a fundamental characteristic of T2DM, arises when liver, adipose, and muscle cells improperly utilize the insulin produced by islet β-cells[13]. Impaired glucose homeostasis and insulin resistance lead to the development of cellular hyperglycemia and hyperinsulinemia[52].

      Experimental evidence has indicated that green tea extract possesses the potential to ameliorate insulin resistance and enhance glycemic control[53]. For example, it improved insulin resistance in human HepG2 liver cancer cells by activating the 5'-adenosine monophosphate-activated protein kinase pathway[54]. And this activation mitigated the obstruction of insulin stress signaling pathways caused by the phosphorylation of insulin receptor substrate-1[54]. Furthermore, green tea polyphenols exhibited the capacity to enhance insulin sensitivity in insulin-resistant rats via upregulating insulin signaling protein levels[55]. A previous study showed that kaempferol ameliorates insulin resistance in T2DM rats by modulating hepatic IKK/NF-κB signaling[56]. Spontaneously diabetic Torii rats elevated fasting glucose levels to 139 ± 23 mg/dL at 28 weeks of intervention, and the ingestion of TF significantly reduced the fasting glucose level to 74 ± 11 mg/dL, which may be due to the induction of the increase in incretin secretion by TF[57]. Moreover, it has been demonstrated that TF-DG could effectively improve glucose uptake in insulin-resistant HepG2 cells and regulate glucose levels in diabetic zebrafish[58]. Additionally, it has been speculated that the richness of tea polysaccharides and polyphenols in yellow tea may contribute to the improvement of insulin resistance and the imbalance of glucolipid metabolism[59]. Among the polysaccharides from black (fully fermented), green (unfermented), oolong (semi-fermented), and dark (post-fermented) teas, black tea polysaccharides exhibited superior efficacy in controlling blood glucose levels and improving insulin resistance, indicating that the fermentation degree significantly increases the hypoglycemic effect of tea polysaccharides[60]. An in vitro experiment reported that pu-erh tea polysaccharides exhibit similar properties to glucose transporter type 4 and peroxisome proliferator-activated receptor γ by improving insulin resistance and reducing blood glucose levels, which could enhance adipocyte differentiation and glucose uptake[61].

    • Carbohydrates constitute the primary exogenous sugars for the body, and starchy foods contribute significantly to overall energy intake. Upon ingestion, starch undergoes initial hydrolysis by salivary and α-amylase, resulting in the production of reducing sugars like maltose and maltotriose. Subsequently, α-glucosidase further hydrolyzes these intermediates to yield glucose[62]. Thus, the two enzymes mentioned above both play crucial roles in regulating starch digestion, and inhibiting their activity has been proposed as a strategy to impede starch digestion and attenuate the rapid increase in postprandial blood glucose levels[63].

      Notably, the inhibitory impact on α-glucosidase was significantly augmented through the galloylation of polyphenols[64]. Nongalloylated polyphenols, such as EGC, epiafzelechin, and EC, showed a weaker inhibitory activity than their corresponding galloylated polyphenols EGCG, epiafzelechin-3-gallate, and ECG, respectively[64]. In addition, in the cases of tea polyphenols, typically comprising catechins and TFs, it has been reported that the presence of 3- and 3'-galloyl moiety on the C ring enhances the affinity of catechins and TFs for α-amylase, thereby heightening the inhibitory activities of both polyphenols against the enzyme[65]. Among four different tea extracts (black tea, green tea, oolong tea, and dark tea extracts), black tea extract exhibited the most pronounced hypoglycemic activity, presumably due to the rich content of TFs in black tea, which inhibited sucrase-isomaltase activity and thus delayed the hydrolysis of isomaltose, maltose, and sucrose, leading to lower postprandial blood glucose[66]. Another investigation revealed that oolong tea polyphenols, 3′′-methyl-epigallocatechin gallate (EGCG3″Me) and EGCG, exhibited inhibitory effects against α-amylase with IC50 values of 0.375, 0.572, and 0.350 mg/mL, respectively[67]. In the realm of quercetin glycosides, quercetin-3-O-(6"-O-galloyl)-β-galactoside (IC50 value: 1.35 ± 0.06 μM) and quercetin-3-O-(3"-O-galloyl)-β-galactoside (IC50 value: 0.97 ± 0.02 μM) emerged as the most potent α-glucosidase inhibitors among the tested compounds. Their inhibitory potency surpassed that of the positive control acarbose (IC50 value: 50.58 ± 0.25 μM) by approximately 37 and 52 times, respectively[68]. Pu-erh dark tea polysaccharide has been reported to lower blood glucose levels in starch-fed mice by inhibiting α-glucosidase activity[69]. A study by Xu et al.[70] showcased that polysaccharides isolated from pu-erh tea possess anti-α-glucosidase activities comparable to or even superior to the clinically used antidiabetic drug acarbose. Interestingly, the anti-α-glucosidase activities demonstrated an increase with the fermentation time of pu-erh tea, suggesting that longer fermentation may lead to the polymerization of proteins and polysaccharides, thereby altering their configuration and conformation and enhancing biological activity. Furthermore, it was reported that tea polysaccharides with smaller molecular weights exhibit better biological activities, such as lowering blood glucose and antioxidant activity, andα-amylase inhibition was significantly and positively correlated with arabinose or galactose content[71]. Moreover, a recent study highlighted the pu-erh tea polysaccharides, which was characterized by the highest total protein and phenolic contents, and displayed the strongest α-glucosidase inhibitory and antidiabetic activities compared to polysaccharides from the other five tea categories

    • Numerous studies have shown that excessive consumption of foods rich in sugar and fat may disturb the natural balance of gut flora and contribute to the onset of DM[24]. Bioactive compounds in tea could increase probiotic levels by modulating the gut flora, thereby improving gut health to alleviate DM.

      Nie et al. observed a decreased ratio of the major phyla Firmicutes/Bacteroidetes and a significant reduction of Bifidobacteria in patients with DM[73]. Another study also confirmed the former finding that the genera Fusobacterium, Blautia, and Ruminococcus were positively associated with DM, while the genera Bifidobacterium, Akkermansia, Roseburia, Faecalibacterium, and Bacteroides were negatively associated with DM[74]. Flavonoids modulate the intestinal flora, increase the diversity and abundance of beneficial bacterial species, and improve intestinal barrier function, thereby reducing insulin resistance[75]. Black tea contains high levels of water-soluble dietary fiber, such as the oxidative polymerization products of tea polysaccharides and polyphenols (e.g., catechins and TFs). These components have the potential to improve lipid and glucose metabolism by regulating the intestinal flora[76]. Huang et al. found that bound polyphenols could modulate diabetic rats' imbalanced microbial community by significantly decreasing harmful bacteria, such as Proteobacteria[77]. A previous animal study demonstrated that the oral administration of EGCG at a dose of 100 mg/kg daily for eight weeks improved glucose homeostasis by increasing glucose tolerance in diabetic mice[78]. Additionally, this diet intervention led to an elevation in the population of bacteria from the Christensencelaceae family while concurrently decreasing the prevalence of Enterobacteriaceae in the intestine of diabetic mice[78]. In addition, polyphenols, such as EGCG, EGC, GC, and other catechins, demonstrated the capacity to hinder the proliferation of numerous pathogens, such as Staphylococcus, Salmonella, Clostridium perfringens, Escherichia coli, and certain gram-negative mimics of the genus Bacillus[73]. These actions have the potential to contribute to the enhancement of intestinal microecology, which may be beneficial for managing DM[73]. It has been shown that tea polysaccharides might exhibit hypoglycemic effects through the regulation of gut microbiota diversity and the augmentation of the relative prevalence of beneficial genera[79]. The antidiabetic effects of Liupao dark tea may be attributed to the increased amount of beneficial bacteria, such as Bacteroides, S24-7, Lactobacillus, Clostridiales, Prevotella, and Ruminococcaceae, in the gut microbiota, which might be modulated by the high contents of polyphenols[80]. These results suggest that the intake of bioactive components from teas may lead to a more balanced environment to promote gut microbiota diversity and maintain a healthy state.

    • Inflammatory cytokines are linked to the development of DM, and inflammatory responses may lead to insulin resistance, which in turn contributes to the development of DM[81]. Medicine targeting inflammatory cytokines is considered as one of the strategies for preventing and managing DM.

      Tumor necrosis factor α (TNF-α) is a proinflammatory cytokine generated by adipose cells. It can cause an increase in the release of fatty acids by adipocytes and resulted in increased levels of free fatty acids which deteriorate insulin signaling and decrease insulin secretion[81]. In contrast, IL-10 is an anti-inflammatory cytokine produced by type 2 macrophages and lymphocytes, which play key roles in suppressing pro-inflammatory cytokines production like TNF-α and IL-6[81]. Various studies have demonstrated that bioactive components in teas exert hypoglycemic effects by lowering the concentrations of pro-inflammatory cytokines and elevating the levels of anti-inflammatory cytokines. For example, the anti-inflammatory effect was observed in quercetin by increasing plasma adiponectin and reducing TNF-α levels in diabetic rats[82]. Moreover, tea polysaccharides may increase immunoreactivity by boosting immune cell activity via enhancing the levels of anti-inflammatory cytokines (e.g., IL-10, IgM, IgG, IL-4, IL-2, and IgA ), and decreasing the levels of pro-inflammatory cytokines like TNF-α and IL-6[22]. Additionally, the beneficial impact of caffeine in KK-Ay mice primarily resulted from its ability to diminish the expression of inflammatory cytokine expression (TNF-α, IL-6, and MCP-1) and ameliorate fatty liver conditions[83]. In addition, the anti-inflammatory effect of TFs should also be considered as they are the major phenolic compounds of black tea and have been reported to inhibit nitric oxide synthase by downregulating the activation of NF-κB in macrophages[84].

    • The bioactive compounds present in tea contribute to the regulation of blood glucose levels by promoting/inhibiting the expressions of genes and proteins involved in glycometabolism and the insulin signaling pathway[85].

      It has been reported that EGCG promoted the tyrosine phosphorylation expressions of the insulin receptor and insulin receptor substrate-1, and inhibited the expression of phosphoenolpyruvate carboxykinase gene for the treatment of DM[86]. In addition, it also lowered the mRNA expression of the phosphoenolpyruvate carboxykinase in H4IIE cells, as well as in the liver tissue and adipose of db/db mice[87]. In addition, it was reported that a supplement of tea polyphenols could improve insulin sensitivity by upregulating the insulin signaling protein levels in insulin-resistant rats[55]. Another study showed that the hypoglycemic mechanism of theasinensin A and B involved the facilitation of glucose transporter 4 translocation to the plasma membrane, thus enhancing glucose intake in rat skeletal muscle cells, which was mediated by the CaMKK/AMPK signaling pathway[88]. Following treatment with tea polysaccharides, there was a notable augmentation in insulin secretion under high glucose conditions (25 mM). In addition, this treatment resulted in the upregulation of gene transcriptions for GLUT2, PKA, INS-2, INS-1, GLP-1R, GCK, and PDX-1 at the mRNA level, alongside increased expression of PDX-1 at the protein level[89]. Furthermore, the antidiabetic effects of tea polysaccharides were counteracted by PKA and AC inhibitors but not by PLC inhibitors, suggesting that tea polysaccharides enhanced antidiabetic activity through the cAMP-PKA signaling pathway[89]. Li et al. evaluated the hypoglycemic effect and possible mechanism of tea polysaccharides in T2DM mice model[90]. It was found that tea polysaccharides enhanced the expression of pivotal proteins within the PI3K/Akt signaling pathway, encompassing GLUT4, p-Akt, and PI3K, which indicated the participation of the PI3K/Akt signal pathway in the hypoglycemic mechanism of tea polysaccharides[90]. Moreover, polyphenols, polysaccharides, and caffeine exhibited the capacity to enhance blood lipid and antioxidant levels, effectively reducing rat serum leptin levels and the expression levels of the IL-6 and TNF-α genes[91].

    • DM is often associated with many complications, including diabetic cardiovascular dyslipidemia, diabetic retinopathy, diabetic foot infections, diabetic nephropathy, diabetic neuropathy, and diabetic hepatopathy. Some reports suggesting that these complications can be improved by the bioactive compounds in tea.

      TFs and catechins effectively mitigated the disruption of insulin signaling caused by high glucose levels[92]. In addition, they also curbed lipid accumulation, suppressed fatty acid synthesis, and promoted fatty acid oxidation through the activation of the LKB1-AMPK pathway[92]. The lack of insulin deficiency and insulin resistance can trigger exaggerated vascular constriction, leading to an increased risk of diabetic cardiovascular dyslipidemia[93]. Another study also confirmed the above finding that black tea polyphenols enhance vasoconstriction by modulating the PI3K-Akt pathway and endothelial nitric oxide synthase phosphorylation[93]. EC destroyed glycated human serum albumin in a dose-dependent manner and decreased the accumulation of advanced glycosylation end products in the retina, thereby having beneficial effects on diabetic retinopathy[94]. It has been shown that patients with diabetes treated with EGCG or green tea polyphenols can sustain normal levels of apoptosis in podocytes, but the proportion of apoptotic podocytes were significantly increased in untreated diabetes patients[95]. Additionally, the potential effect of old tree white tea on diabetic nephropathy is attributed to its high contents of polyphenols (particularly EGCG) and polysaccharides[96].

      This agrees with the findings presented by Xu et al.[97] and Yi et al.[98], which indicated that the hypoglycemic and antioxidant properties of tea polysaccharides and tea polyphenols have the potential to significantly ameliorate and prevent diabetic kidney injury. An in vivo investigation revealed that tea polyphenols could potentially inhibit autonomic dysfunction by preventing alterations in arterial pressure variability[99]. Additionally, another study proposed that tea polyphenols could exert significant effects on diabetic liver injury through their antioxidant activity[100].

    • DM and its associated complications have emerged as a significant public health issue. Current clinical medicines usually produce some toxic side effects; thus, developing new, safe, and effective hypoglycemic drugs from natural products is necessary. Tea exhibits antidiabetic activity due to its richness in various active components, such as tea polyphenols, tea polysaccharides, and alkaloids. Epidemiological and clinical investigations have demonstrated an inverse relationship between regular tea consumption and the incidence of DM. Furthermore, in vitro and in vivo experiments have showcased the beneficial effects of tea in preventing and managing DM and its associated complications. The bioactive components in teas protect against DM and diabetic complications via several possible mechanisms, including the improvement of insulin resistance, inhibition of digestion and absorption of carbohydrates (inhibit α-amylase and α-glucosidase activity), regulations of gut microbiota, inflammatory cytokines, and gene and protein expressions of the insulin signaling pathway, as well as amelioration of DM complications.

      The potential antidiabetic properties of tea are intricately linked to its bioactive compounds. However, it's important to note that the chemical composition of tea can vary significantly based on factors such as the tea plant cultivar, degree of fermentation during processing, and tea preparation methods (including variables like the quantity of tea used, brewing time, and water volume). Consequently, this variation can lead to inconsistent antidiabetic effects observed in studies using tea from different sources. Hence, it is crucial to isolate and purify individual bioactive compounds to evaluate their specific antidiabetic effects, in addition, further structural modifications (e.g., hydroxy methylation, sulfation, acetylation, etc.) of compounds may improve its hypoglycemic effects. Such an approach could help elucidate the primary antidiabetic components present in tea and have practical implications for optimizing tea processing methods. However, their clinical applications encounter impediments similar to those of other natural products, such as limited solubility and oral bioavailability, thus hindering the therapeutic delivery of tea and its bioactive components, notably tea polyphenols. Furthermore, variations in the bioavailability of tea constituents due to diverse physiological conditions among individuals and populations warrant consideration. Consequently, a critical focus of future research lies in enhancing the bioavailability of tea. In recent years, nanotechnology has witnessed significant advancements, offering a promising avenue for addressing these issues. Therefore, developing novel and sustainable techniques such as nanotechnologies, including metal-based, carbohydrate-based, lipid-based, protein-based, and polymer-based nanoparticles, to enhance the therapeutic delivery of these invaluable natural compounds is a crucial necessity.

    • The authors confirm contribution to the paper as follows: Study conception and design: Gao J, Lin Z, Dai W; data collection: Gao J, Chen D, Lin ZY, Peng J, Yu S, Zhou C, Jiang H, Sun R; analysis and interpretation of results: Gao J, Chen D, Dai W; draft manuscript preparation: Gao J, Dai W. All authors reviewed the results and approved the final version of the manuscript.

    • Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.

      • This work was supported by the Zhejiang Province Natural Science Foundation (LR23C160002), the Science and Technology Innovation Project of the Chinese Academy of Agricultural Sciences (CAAS-ASTIP-2023-TRICAAS), and the National Natural Science Foundation (32172630 and 31972467).

      • The authors declare that they have no conflict of interest.

      • Copyright: © 2023 by the author(s). Published by Maximum Academic Press, Fayetteville, GA. This article is an open access article distributed under Creative Commons Attribution License (CC BY 4.0), visit https://creativecommons.org/licenses/by/4.0/.
    Figure (2)  Table (2) References (100)
  • About this article
    Cite this article
    Gao J, Chen D, Lin Z, Peng J, Yu S, et al. 2023. Research progress on the antidiabetic activities of tea and its bioactive components. Beverage Plant Research 3:32 doi: 10.48130/BPR-2023-0032
    Gao J, Chen D, Lin Z, Peng J, Yu S, et al. 2023. Research progress on the antidiabetic activities of tea and its bioactive components. Beverage Plant Research 3:32 doi: 10.48130/BPR-2023-0032

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return